BOULDER, Colo., July 6, 2015 /PRNewswire/ -- Array BioPharma
Inc. (Nasdaq: ARRY) today announced that its Chief Executive
Officer, Ron Squarer, will present
at the Cantor Fitzgerald 2015 Healthcare Conference in New York
City. The public is welcome to participate in the conference
through a webcast on the Array BioPharma
website.
|
Event:
|
Cantor Fitzgerald
2015 Healthcare Conference
|
|
Presenter:
|
Ron Squarer, Chief
Executive Officer
|
|
Date:
|
Wednesday, July 8,
2015
|
|
Time:
|
1:00 p.m. Eastern
Time
|
|
Webcast:
|
www.arraybiopharma.com
|
About Array BioPharma
Array BioPharma Inc. is a
biopharmaceutical company focused on the discovery, development and
commercialization of targeted small molecule drugs to treat
patients afflicted with cancer. Six Phase 3 studies are
currently advancing. These programs include three cancer drugs,
binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 /
wholly-owned) and selumetinib (AstraZeneca). For more
information on Array, please go to www.arraybiopharma.com.
|
CONTACT:
|
Tricia
Haugeto
|
|
Array BioPharma
Inc.
|
|
303-386-1193
|
|
thaugeto@arraybiopharma.com
|
Logo -
http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-cantor-fitzgerald-2015-healthcare-conference-300109222.html
SOURCE Array BioPharma Inc.